Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: GlobeNewswire
SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the first quarter ended March 31, 2024, after the market close on Monday, May 13, 2024. Management will then host a webcast and conference call at 4:30 p.m. ET on May 13. Title:Capricor Therapeutics First Quarter 2024 Financial Results and Recent Corporate Update Conference Call and WebcastDate:Monday, May 13, 2024Time:4:30 p.m. ETConference Call Details:Toll-Free: 1-888-886-7786International: 1-416-764-8658Conference ID: 01529679Participants can use guest dial-in numbers above and be answered by an operator or click the Call me™ link for instant telephone access to the event.Webcast:Webcast Link - Click Here A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s websit
Show less
Read more
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) had its price target raised by analysts at LADENBURG THALM/SH SH from $24.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.MarketBeat
CAPR
Earnings
- 5/13/24 - Miss
CAPR
Sec Filings
- 5/15/24 - Form 8-K
- 5/15/24 - Form 8-K
- 5/14/24 - Form 10-Q
- CAPR's page on the SEC website